Sangamo Therapeutics
SGMO
#10416
Rank
ยฃ22.89 M
Marketcap
ยฃ0.05528
Share price
0.00%
Change (1 day)
-84.75%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : ยฃ58.95 Million

According to Sangamo Therapeutics 's latest financial reports the company's total liabilities are ยฃ58.95 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sangamo Therapeutics - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31ยฃ54.95 M-12.55%
2024-12-31ยฃ62.84 M-2.87%
2023-12-31ยฃ64.7 M-70.74%
2022-12-31ยฃ0.22 B-13.87%
2021-12-31ยฃ0.25 B-20.67%
2020-12-31ยฃ0.32 B107.26%
2019-12-31ยฃ0.15 B-11.16%
2018-12-31ยฃ0.17 B140.36%
2017-12-31ยฃ73.13 M315.93%
2016-12-31ยฃ17.58 M5.09%
2015-12-31ยฃ16.73 M-28.78%
2014-12-31ยฃ23.49 M102.61%
2013-12-31ยฃ11.59 M6.27%
2012-12-31ยฃ10.91 M135.43%
2011-12-31ยฃ4.63 M0.89%
2010-12-31ยฃ4.59 M-52.52%
2009-12-31ยฃ9.67 M13.86%
2008-12-31ยฃ8.49 M43.33%
2007-12-31ยฃ5.92 M64.14%
2006-12-31ยฃ3.61 M-44.23%
2005-12-31ยฃ6.47 M429.57%
2004-12-31ยฃ1.22 M39.26%
2003-12-31ยฃ0.87 M-28.92%
2002-12-31ยฃ1.23 M-32.86%
2001-12-31ยฃ1.84 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
ยฃ89.41 B 151,582.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ62.23 B 105,467.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ8.09 B 13,624.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
ยฃ32.13 B 54,407.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ24.53 B 41,520.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ61.81 B 104,758.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ3.02 B 5,037.06%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.77 B 2,914.33%๐Ÿ‡บ๐Ÿ‡ธ USA